Article Information
- Received August 9, 2020
- Revision received October 27, 2020
- Accepted October 27, 2020
- Published online February 2, 2021.
Author Information
- Heather A. Born1,2,
- Luis A. Martinez1,2,
- Amber T. Levine1,2,
- Sarah E. Harris1,2,
- Shubhangi Mehra1,2,3,
- Wai Ling Lee1,2,
- Scott V. Dindot4,
- Kevin R. Nash5,
- Jill L. Silverman6,
- David J. Segal6,
- Edwin J. Weeber5 and
- Anne E. Anderson1,2,7
- 1Cain Foundation Laboratories, Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, Houston, TX 77030
- 2Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030
- 3Rice University, Houston, TX 77005
- 4Department of Veterinary Pathobiology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX 77843
- 5Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, FL 33612
- 6MIND Institute and Department of Psychiatry and Behavioral Sciences, University of California Davis School of Medicine, Sacramento, CA 95817
- 7Departments of Neuroscience and Neurology, Baylor College of Medicine, Houston, TX 77030
- Correspondence should be addressed to Anne E. Anderson at annea{at}bcm.edu.
Author contributions
Author contributions: H.A.B. and A.E.A. designed research; H.A.B., L.A.M., A.T.L., S.E.H., and W.L.L. performed research; S.V.D., K.R.N., J.L.S., D.J.S., and E.J.W. contributed unpublished reagents/analytic tools; H.A.B., L.A.M., A.T.L., S.E.H., S.M., and W.L.L. analyzed data; H.A.B. and A.E.A. wrote the paper.
Disclosures
The authors declare no competing financial interests.
This work was supported by generous funding from the Foundation for Angelman Syndrome Therapeutics (A.E.A., S.V.D., K.R.N., J.L.S., D.J.S., and E.J.W.), the National Institute of Neurological Disorders and Stroke Brain Disorders and Development Training Grant T32NS043124–07 (to H.A.B. and L.A.M.), a postdoctoral research fellowship from the American Epilepsy Society and the Pediatric Epilepsy Research Foundation (H.A.B.), and the Jan and Dan Duncan Neurological Research Institute Zoghbi Scholar Award (H.A.B.).
Funding
Foundation for Angelman Syndrome Therapeutics (FAST)
HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
T32NS043124-07American Epilepsy Society (AES)
Jan and Dan Duncan Neurological Research Institute Zoghbi Scholar Award
Other Version
- You are viewing the most recent version of this article.
- previous version (February 02, 2021).
Online Impact